Danazol

In: JAMA: The Journal of the American Medical Association · 1976 · vol. 235(3) , pp. 250 · doi:10.1001/jama.1976.03260290012009 · W4230586914
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-07-05

Danazol therapy for endometriosis may provide temporary symptom relief, but active disease and symptoms recur in 8-12 months after discontinuation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To the Editor.— An article in MEDICAL NEWS (233:942-943, 1975) gave special reference to danazol. Having worked with this new medication1and having heard the article presented by Dr Niels H. Lauersen in Los Angeles at the April meeting of the American Fertility Society, I must take exception to the implication that danazol causes permanent relief of the symptoms of endometriosis, especially since the follow-up period after the medication is discontinued is inadequate (by Dr Lauersen's admission to my question from the floor in Los Angeles). Active endometriosis does recur, with its attendant symptoms, within eight to 12 months after danazol therapy is stopped. Certainly this medication may prove to be beneficial, but let us not go overboard until we thoroughly assess these patients for a long enough period of time after the therapy is discontinued. I realize that reference was made to Greenblatt's study of danazol: The drug

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK